HGA, Crinetics Partner on Lab and Office Spaces

Design firm HGA partnered with Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company,, to design and construct new lab and office spaces within Crinetics’ 94,230-square-foot headquarters in San Diego’s Sorrento Mesa neighborhood. Slated for delivery in multiple construction phases, with the first completed in January, HGA developed a total of 21,000 square feet of new chemistry and biology laboratories within the two-story building. 

Crinetics leased the building at 6055 Lusk Blvd. in 2022 to deepen its in-house R&D organization to fulfill its commitment to create important new therapeutic options for people living with endocrine diseases and endocrine-related tumors as well as accommodate its growing workforce. The new headquarters, which opened in January following the completion of the first construction phase, will include medical, analytical and formulation chemistry laboratories, along with tissue/cell culture, radiochemistry and mass spectrometry support spaces.

“The scale of this project and its impact on Crinetics’ endocrine therapies is a point of pride for the HGA team,” said Trevor Wells, science + technology principal at HGA. “We enjoyed partnering with Crinetics’ in bringing their vision to life, with the goal of designing a collaborative, flexible and specialized lab facility to meet their multifaceted needs and evolve with their employees.”